Healthspan
@healthspanmed.bsky.social
Healthspan is the first online medical clinic dedicated to fighting age-related diseases and increasing human performance by fighting cellular senescence.
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
December 13, 2025 at 10:00 AM
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
New research shows hair loss isn’t just hormonal — it’s tied to aging inside the follicle.
When autophagy (the cell’s recycling system) declines, stem cells slow down, senescent cells build up, and follicles struggle to re-enter the growth phase.
www.gethealthspan.com/research/ar...
When autophagy (the cell’s recycling system) declines, stem cells slow down, senescent cells build up, and follicles struggle to re-enter the growth phase.
www.gethealthspan.com/research/ar...
A Novel Synergistic Strategy for Hair Loss Prevention and Reversal: Rapamycin, Finasteride, and Minoxidil | Healthspan
Speak to a doctor about longevity protocols and prescriptions.
gethealthspan.com
December 9, 2025 at 8:00 PM
New research shows hair loss isn’t just hormonal — it’s tied to aging inside the follicle.
When autophagy (the cell’s recycling system) declines, stem cells slow down, senescent cells build up, and follicles struggle to re-enter the growth phase.
www.gethealthspan.com/research/ar...
When autophagy (the cell’s recycling system) declines, stem cells slow down, senescent cells build up, and follicles struggle to re-enter the growth phase.
www.gethealthspan.com/research/ar...
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
December 7, 2025 at 8:00 PM
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
The latest research reveals mitochondrial breakdown as a root driver of aging.
We created a framework to track their health, diagnose decline, and apply interventions that protect lifespan.
www.youtube.com/watch?v=QpW...
We created a framework to track their health, diagnose decline, and apply interventions that protect lifespan.
www.youtube.com/watch?v=QpW...
The Mitochondrial Optimization Framework: Analyzing the Latest Research on Diagnosis and Longevity
Mitochondria are not just “powerhouses of the cell” — they are central regulators of how we age, how much energy we can produce, and how resilient our brain ...
www.youtube.com
December 7, 2025 at 1:00 AM
The latest research reveals mitochondrial breakdown as a root driver of aging.
We created a framework to track their health, diagnose decline, and apply interventions that protect lifespan.
www.youtube.com/watch?v=QpW...
We created a framework to track their health, diagnose decline, and apply interventions that protect lifespan.
www.youtube.com/watch?v=QpW...
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
December 6, 2025 at 10:00 AM
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
New Research Review: SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging
gethealthspan.com/science/art...
gethealthspan.com/science/art...
December 4, 2025 at 1:00 AM
New Research Review: SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging
gethealthspan.com/science/art...
gethealthspan.com/science/art...
🚨 How Endogenous Fructose Fuels Inflammation and Accelerates Aging—Watch Now
www.youtube.com/watch?v=vBo...
www.youtube.com/watch?v=vBo...
November 28, 2025 at 1:00 AM
🚨 How Endogenous Fructose Fuels Inflammation and Accelerates Aging—Watch Now
www.youtube.com/watch?v=vBo...
www.youtube.com/watch?v=vBo...
🧠 Is Alzheimer’s really a disease of misfolded proteins—or a crisis of cellular energy?
For decades, the dominant theory of Alzheimer’s disease has focused on the growth of amyloid plaques. But a growing body of research points to a different culprit that may come earlier: mitochondrial dysfunction
For decades, the dominant theory of Alzheimer’s disease has focused on the growth of amyloid plaques. But a growing body of research points to a different culprit that may come earlier: mitochondrial dysfunction
November 27, 2025 at 2:00 PM
🧠 Is Alzheimer’s really a disease of misfolded proteins—or a crisis of cellular energy?
For decades, the dominant theory of Alzheimer’s disease has focused on the growth of amyloid plaques. But a growing body of research points to a different culprit that may come earlier: mitochondrial dysfunction
For decades, the dominant theory of Alzheimer’s disease has focused on the growth of amyloid plaques. But a growing body of research points to a different culprit that may come earlier: mitochondrial dysfunction
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
November 27, 2025 at 1:00 AM
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
More than a century ago, Alois Alzheimer’s landmark findings on amyloid plaques and neurofibrillary tangles established the amyloid-centric model of Alzheimer’s disease (AD)—a perspective that has guided much of the field for decades. However, mounting evidence indicates that vascular insufficiency
November 22, 2025 at 8:00 PM
More than a century ago, Alois Alzheimer’s landmark findings on amyloid plaques and neurofibrillary tangles established the amyloid-centric model of Alzheimer’s disease (AD)—a perspective that has guided much of the field for decades. However, mounting evidence indicates that vascular insufficiency
🧬 Is aging just wear-and-tear, or is it a built-in flaw in our biological “software”?
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
November 22, 2025 at 1:00 AM
🧬 Is aging just wear-and-tear, or is it a built-in flaw in our biological “software”?
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
November 21, 2025 at 1:00 AM
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
November 21, 2025 at 1:00 AM
New Research Review: The Surprising Role of Rapamcyin in Treating Long COVID and Post-Viral Symptoms: hspan.io/j5Cyvz
For years, midlife weight gain in women was blamed on a simple drop in estrogen. But new research shows it’s far more complex—and it at least partially starts in the brain.
November 19, 2025 at 1:00 AM
For years, midlife weight gain in women was blamed on a simple drop in estrogen. But new research shows it’s far more complex—and it at least partially starts in the brain.
🧬 Why are geroscientists interested in SGLT2 inhibitors for longevity?
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
November 18, 2025 at 8:00 PM
🧬 Why are geroscientists interested in SGLT2 inhibitors for longevity?
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
For years, midlife weight gain in women was blamed on a simple drop in estrogen. But new research shows it’s far more complex—and it at least partially starts in the brain.
November 15, 2025 at 8:00 PM
For years, midlife weight gain in women was blamed on a simple drop in estrogen. But new research shows it’s far more complex—and it at least partially starts in the brain.
New Research Review: SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging
gethealthspan.com/science/art...
gethealthspan.com/science/art...
November 15, 2025 at 10:00 AM
New Research Review: SGLT2 Inhibitors as Metabolic Senolytics: Clearing Senescent Cells to Combat Pathological Aging
gethealthspan.com/science/art...
gethealthspan.com/science/art...
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
November 14, 2025 at 9:00 AM
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
November 13, 2025 at 11:48 PM
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
October 14, 2025 at 7:00 PM
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
🧬 Why are geroscientists interested in SGLT2 inhibitors for longevity?
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
September 11, 2025 at 7:00 PM
🧬 Why are geroscientists interested in SGLT2 inhibitors for longevity?
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
Approved for Type II Diabetes, these drugs differ from Metformin or Acarbose. They prevent glucose reabsorption in kidneys, leading to the excretion of 70-90g of glucose daily.
Here's why longevity researchers are intrigued. 👇
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
September 11, 2025 at 1:00 PM
🧬 Why are longevity researchers increasingly excited about SGLT2 inhibitors?
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
September 11, 2025 at 12:00 AM
1. 🧠 What if Alzheimer’s isn’t caused by plaques at all—but by an energy crisis inside your brain cells?
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
The research of Dr. Francisco Gonzalez-Lima on mitochondrial dysfunction in AD—and the potential of methylene blue to restore neuronal energy—you see a radically different framing of the disease
🧬 Is aging just wear-and-tear, or is it a built-in flaw in our biological “software”?
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
September 10, 2025 at 7:00 PM
🧬 Is aging just wear-and-tear, or is it a built-in flaw in our biological “software”?
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
Dr. João Pedro de Magalhães proposes an interesting perspective: our DNA is the hardware, while the epigenome acts as software.
Over time, this “software” may become maladaptive, driving the aging
Read more 🧵👇
Hair loss is often dismissed as a mere cosmetic issue—but mounting evidence suggests it’s a powerful biomarker of systemic aging.
Recent research highlights two cellular processes at the heart of follicle health: senescence and autophagy (a cellular “cleanup” program).
Let's review 🧵👇
Recent research highlights two cellular processes at the heart of follicle health: senescence and autophagy (a cellular “cleanup” program).
Let's review 🧵👇
September 1, 2025 at 8:00 AM
Hair loss is often dismissed as a mere cosmetic issue—but mounting evidence suggests it’s a powerful biomarker of systemic aging.
Recent research highlights two cellular processes at the heart of follicle health: senescence and autophagy (a cellular “cleanup” program).
Let's review 🧵👇
Recent research highlights two cellular processes at the heart of follicle health: senescence and autophagy (a cellular “cleanup” program).
Let's review 🧵👇